HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A rapid immunostaining method for scirrhous gastric cancer during surgery using a monoclonal antibody.

Abstract
In the microscopic examination of gastric cancer, it is sometimes difficult to identify scirrhous carcinoma cells, because they grow individually into the fibrous tissue. In this study we used an anti-scirrhous carcinoma monoclonal antibody S202, which was reactive with 100 per cent of the cells belonging to this type of carcinoma, in a rapid immunostaining procedure to identify the limit of tumor invasion at the time of surgery. S202 was applied using this new immunostaining method and the results compared with those obtained by the routine immunohistological method. Five minutes incubation was sufficient to stain the tumor cells with biotin-conjugated S202 and the entire procedure took only 14-15 mins. There was no difference between the new and routine methods in terms of distribution of S202-positive carcinoma cells. This rapid staining method enabled a clearer recognition of infiltrating tumor cells in the frozen sections of tissue specimens, than was previously possible. This technique will thus make it possible to determine the limit of tumor extension in resected tissues accurately and rapidly during surgery.
AuthorsT Yokota, T Takahashi, T Yamaguchi, K Sawai, E Otsuji, K Kitamura, H Suzuyama, T Yamane, Y Fujita
JournalThe Japanese journal of surgery (Jpn J Surg) Vol. 18 Issue 2 Pg. 232-4 (Mar 1988) ISSN: 0047-1909 [Print] Japan
PMID2455827 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Neoplasm
  • Biotin
Topics
  • Adenocarcinoma, Scirrhous (pathology, surgery)
  • Antibodies, Monoclonal
  • Antibodies, Neoplasm
  • Biotin
  • Humans
  • Immunohistochemistry
  • Intraoperative Care
  • Staining and Labeling
  • Stomach Neoplasms (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: